Detalles de la búsqueda
1.
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Br J Cancer
; 130(11): 1783-1794, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519705
2.
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Int J Clin Oncol
; 29(2): 96-102, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183554
3.
The efficacy and safety of anamorelin among patients with diabetes.
Int J Clin Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722487
4.
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Cancer Sci
; 114(2): 630-639, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285515
5.
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.
Invest New Drugs
; 41(2): 356-364, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036580
6.
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
J Neurooncol
; 162(2): 435-441, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977845
7.
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 40(2): 403-410, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34633575
8.
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
Invest New Drugs
; 40(2): 411-419, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716848
9.
Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.
BMC Cancer
; 22(1): 73, 2022 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039004
10.
Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
Jpn J Clin Oncol
; 52(6): 599-608, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411369
11.
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.
Support Care Cancer
; 30(2): 1633-1641, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34550461
12.
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.
Cancer Sci
; 112(1): 359-368, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098119
13.
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.
Invest New Drugs
; 39(2): 571-577, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955628
14.
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.
Invest New Drugs
; 39(6): 1716-1723, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34046801
15.
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.
Invest New Drugs
; 39(6): 1732-1741, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34259953
16.
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
BMC Cancer
; 21(1): 1247, 2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798865
17.
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
Jpn J Clin Oncol
; 51(12): 1736-1743, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34642738
18.
Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.
Support Care Cancer
; 29(7): 3961-3970, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392773
19.
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
Int J Clin Oncol
; 26(4): 659-669, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415571
20.
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
Invest New Drugs
; 38(5): 1612-1617, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128667